Yahoo! Finance: ARWR NewsLatest Financial News for ARROWHEAD RESEARCHCalando Pharmaceuticals Announces Next siRNA Therapeutic Candidate for Oncology (Business Wire)- September 15, 2008 PASADENA, Calif.----Calando Pharmaceuticals, a majority-owned subsidiary of Arrowhead Research Corporation , announced today that pre-clinical development of a second siRNA oncology therapeutic, CALAA-02, is underway.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080915/200809150056... ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi (EDGAR Online)- September 11, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/080911/arwr8-k.html Calando Pharmaceuticals Phase II Clinical Study Opens to Patient Enrollment (Business Wire)- September 11, 2008 PASADENA, Calif.----Calando Pharmaceuticals, Inc., a majority owned subsidiary of Arrowhead Research Corporation , announced today that it has initiated a Phase II clinical trial in the United States evaluating the safety and efficacy of its drug candidate, IT-101 in patients with platinum-sensitive ovarian cancer.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080911/200809110053... Arrowhead Completes Previously Announced Registered Direct Offering (Business Wire)- September 9, 2008 PASADENA, Calif.----Arrowhead Research Corporation announced today that it has completed its previously announced registered direct offering, increasing total gross proceeds to approximately $6.9 million.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080909/200809090056... |